Here are a few highlights of cancer research news that have recently caught my attention:

• The NIH launched the Exceptional Responders Initiative which aims to study the molecular factors of tumors for better cancer patient responses to drug therapy.
• A study by researchers at Vanderbilt found that the use of FDG-PET Technology was less reliable in certain geographic locations where fungal lung disease is more prevalent. For more, see the article in JAMA.
• Scientists at Stanford developed a decoy protein to stop cancer from spreading. Results are published in the latest issue of Nature Chemical Biology.
• Chemo and radiation are safe for babies in the womb according to studies presented at the Annual Congress of the European Society for Medical Oncology.
• Results of a clinical trial on the drug Perjeta reveals success at prolonging life in advanced breast cancer cases.
• Women who go up a skirt size every decade between their 20s and their 60s may be at increased risk for breast cancer according to a study published in BMJ Open.

Please feel free to contact Marisol Hernandez to share any comments.